Europe Patchouli Oil Market Size, Share & Industry Trends Analysis Report By Type (Light and Dark), By Application (Cosmetics & Personal Care, Medicine, Flavorings and Others), By Country and Growth Forecast, 2023 - 2030

Europe Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030


The Europe Pigmentation Disorder Treatment Market would witness market growth of 4.6% CAGR during the forecast period (2023-2030).

Patients must be aware of pigmentation disorders and the available treatment options. Dermatologists, skincare professionals, and healthcare organizations play a crucial role in educating the public about these conditions and the benefits of treatment. In some cultures, having clear and even-toned skin is highly valued, which can drive a higher adoption rate of pigmentation disorder treatments. In contrast, adoption rates are lower in cultures where skin color variations are more accepted.

Social media and beauty influencers influence the adoption of pigmentation for pigmentation disorders. Positive reviews and before-and-after photos can generate interest and encourage individuals to try treatments. The psychological impact of pigmentation disorders, including self-esteem and self-confidence, can drive individuals to seek treatment. As overall skin health and wellness trends gain popularity, more individuals are motivated to address pigmentation concerns as part of their skincare routine.

There is a growing emphasis on skin health and skincare routines among the general population in Europe. People are becoming more conscious of maintaining healthy and clear skin. The increasing awareness of pigmentation disorder treatment in Europe has led to a greater demand for effective and safe treatments. Dermatologists, skincare professionals, and the skincare industry are continually working to provide innovative solutions to address the needs and concerns of individuals with pigmentation disorders in the region. Therefore, the rapidly aging population demographic of this region will be the primary factor driving the expansion of the regional market.

The Germany market dominated the Europe Pigmentation Disorder Treatment Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $76.8 million by 2030. The UK market is exhibiting a CAGR of 3.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.4% during (2023 - 2030).

Based on Type, the market is segmented into Vitiligo, Melasma, and Others. Based on Treatment, the market is segmented into Corticosteroids, Calcineurin Inhibitor, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, & Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Vitiligo
  • Melasma
  • Others
By Treatment
  • Corticosteroids
  • Calcineurin Inhibitor
  • Others
By Distribution Channel
  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Bausch Health Companies Inc
  • Glenmark Pharmaceuticals Limited
  • Obagi Cosmeceuticals LLC
  • AbbVie, Inc.
  • Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
  • Incyte Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Galderma S.A.
  • Viatris, Inc. (Mylan N.V.)
  • Pfizer, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Patchouli Oil Market, by Type
1.4.2 Europe Patchouli Oil Market, by Application
1.4.3 Europe Patchouli Oil Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Europe Patchouli Oil Market, by Type
4.1 Europe Light Market, by Country
4.2 Europe Dark Market, by Country
Chapter 5. Europe Patchouli Oil Market, by Application
5.1 Europe Cosmetics & Personal Care Market, by Country
5.2 Europe Medicine Market, by Country
5.3 Europe Flavorings Market, by Country
5.4 Europe Others Market, by Country
Chapter 6. Europe Patchouli Oil Market, by Country
6.1 Germany Patchouli Oil Market
6.1.1 Germany Patchouli Oil Market, by Type
6.1.2 Germany Patchouli Oil Market, by Application
6.2 UK Patchouli Oil Market
6.2.1 UK Patchouli Oil Market, by Type
6.2.2 UK Patchouli Oil Market, by Application
6.3 France Patchouli Oil Market
6.3.1 France Patchouli Oil Market, by Type
6.3.2 France Patchouli Oil Market, by Application
6.4 Russia Patchouli Oil Market
6.4.1 Russia Patchouli Oil Market, by Type
6.4.2 Russia Patchouli Oil Market, by Application
6.5 Spain Patchouli Oil Market
6.5.1 Spain Patchouli Oil Market, by Type
6.5.2 Spain Patchouli Oil Market, by Application
6.6 Italy Patchouli Oil Market
6.6.1 Italy Patchouli Oil Market, by Type
6.6.2 Italy Patchouli Oil Market, by Application
6.7 Rest of Europe Patchouli Oil Market
6.7.1 Rest of Europe Patchouli Oil Market, by Type
6.7.2 Rest of Europe Patchouli Oil Market, by Application
Chapter 7. Company Profiles
7.1 Takasago International Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Van Aroma
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.3 Ultra International B.V. (Ultra Group)
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 PT Indesso
7.4.1 Company Overview
7.5 Symrise AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Sensient Technologies Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Givaudan S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.6 SWOT Analysis
7.8 International Flavors & Fragrances, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segment & Regional Analysis
7.8.4 Research & Development Expense
7.8.5 SWOT Analysis
7.9 DSM-Firmenich
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. NOW Health Group, Inc.
7.10.1 Company Overview
7.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings